Sales and Marketing

Showing 15 posts of 11526 posts found.

ABPI

Value-based pricing no ‘magic bullet’ – ABPI

November 16, 2010 Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing

UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …
quintiles_john_procter

Pfizer’s John Proctor moves to Quintiles

November 15, 2010 Sales and Marketing John Proctor, Pfizer, Quintiles, UK, appointment, sales and marketing

Quintiles has appointed the former head of Pfizer Health Solutions to lead its own Health Management Solutions (HMS) business. As …
Katina

When should pharma leaders trust their gut instinct?

November 15, 2010 Business Services, Sales and Marketing decision making, leadership, management

One of the most important questions facing leaders is when they should trust their gut instincts. Our work at McKinsey …

Irish cost-effectiveness guidelines published

November 15, 2010 Sales and Marketing Dr Mairin Ryan, Economic Evaluation of Health Technologies, HIQA, Health Information and Quality Authority, IPHA, Ireland, Irish Pharmaceutical Healthcare Association, NICE, hta

The Irish government has published new health technology assessment guidelines to help decision-makers estimate the cost-effectiveness of medical treatments. The …

Bavarian Nordic courting cancer vaccine backers

November 12, 2010 Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010 Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …

Germany to cut drug prices by 2 billion euro

November 12, 2010 Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines

The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …
Avastin packs

NICE stands firm on Avastin rejection

November 12, 2010 Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme

NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …
amanda_callaghan

ABPI appoints communications director

November 11, 2010 Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …

Nycomed’s Q3 undermined by pantoprazole decline

November 11, 2010 Sales and Marketing Daxas, Guangdong Techpool Bio-Pharma, Nycomed, Protium, pantoprazole

Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …

Genzyme again snubs suitor Sanofi

November 10, 2010 Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …

Bayer rebrands pharma division

November 10, 2010 Medical Communications, Sales and Marketing Bayer Healthcare, Bayer cross, Byaer Schering Pharma, Marijn Dekkers, Xarelto, prix galien

The name Bayer Schering Pharma has been consigned to the corporate dustbin as its parent group institutes a branding shake-up. …

NICE limits access to cancer drugs, study confirms

November 10, 2010 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta

NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …

Improving Clinical Site Productivity

November 9, 2010 Sales and Marketing Kinapse, White paper

There are a number of factors in the industry that make clinical trials more costly, more time-consuming and requiring more …

Recycling pharma marketing research

November 8, 2010 Medical Communications, Sales and Marketing Insight Marketing Systems, market research, marketing research, pharma marketing research

Recycling is in vogue. Not just in the consumer market, but across business sectors too. But recycling in the market …
The Gateway to Local Adoption Series

Latest content